相关实验视频

Updated: May 8, 2025

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

评估血液学标志物作为类风湿性关节炎的预后工具

Maryam Masoumi¹, Maryam Bozorgi¹, Zahra Nourmohammadi²

¹Clinical Research and Development Unit, Shahid Beheshti Hospital, Qom University of Medical Sciences, Qom, Iran.

BMC rheumatology

|December 25, 2024

概括

像中性粒细胞-淋巴细胞比率 (NLR) 和血小板-淋巴细胞比率 (PLR) 这样的血液学指数显示出评估类风湿性关节炎 (RA) 活动的前景. 这些标志物与传统的炎症标志物相关,为监测RA提供潜在的成本效益替代品.

科学领域:

类风湿病学类风湿病学
免疫学免疫学免疫学
血液学血液学血液学

背景情况:

风湿性关节炎 (RA) 管理取决于减少炎症,但传统的标记物如CRP,ESR和DAS-28都有局限性.
血液学指数,包括血小板 - 淋巴细胞比率 (PLR),淋巴细胞 - 单细胞比率 (LMR) 和中性粒细胞 - 淋巴细胞比率 (NLR),在 RA 中具有作为可靠的炎症指标的潜力.
这项研究旨在评估这些血液学标志物在不同的RA活性水平上,以确定有效的生物标志物,以区分活跃疾病和缓解.

研究的目的:

评估血液学指数 (PLR,LMR,NLR) 作为类风湿性关节炎 (RA) 活性的生物标志物的疗效.
将这些新型标志物的诊断准确度与传统的炎症标志物 (CRP,ESR) 和疾病活动评分 (DAS-28) 进行比较.
确定具有成本效益和可访问的工具来监测RA炎症和疾病状况.

主要方法:

通过ACR/EULAR 2010标准诊断出305名RA患者,根据DAS28-ESR得分分层分为四组.
在采集的血液样本上进行了完整血清 (CBC) 和血清学测试 (RF,anti-CCP,ANA,CRP).
血小板-淋巴细胞比率 (PLR),淋巴细胞-单细胞比率 (LMR) 和中性粒细胞-淋巴细胞比率 (NLR) 计算并分析了它们与RA活性的相关性.

主要成果:

ROC分析表明,ESR,CRP,NLR和PLR是区分活跃RA和缓解的潜在标志物,ESR显示最高准确度.
中性细胞-淋巴细胞比率 (NLR) 和血小板-淋巴细胞比率 (PLR) 与已知炎症标志物如CRP和ESR显著相关.
发现淋巴细胞-单细胞比 (LMR) 在区分活跃和不活跃的RA疾病状态方面无效.

结论:

中性细胞-淋巴细胞比率 (NLR) 和血小板-淋巴细胞比率 (PLR) 与传统的RA炎症标志物 (CRP,ESR) 有显著的相关性.
与成像技术相比,这些血液学指数为评估RA活动提供了有希望的,潜在的成本效益的替代方案.
需要进一步的研究来验证NLR和PLR在常规RA治疗中的临床实用性和整合.

关键词:

血液学标记物是一种血液学标记物.在LMR中,只有LMR.在NLR中,它是NLR.在PLR PLR中,类风湿性关节炎 (RA) 是一种

更多相关视频

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...